TB

This tool is designed to help clinicians select adults for LTBI testing who are at high-risk for TB exposure or progression to TB disease. The tool calls out 3 groups for testing: foreign-born; immunosuppressed (e.g., HIV, TNF alpha inhibitor use, steroids, organ transplant); and contacts.

The Stop TB Partnership developed a set of free campaign materials for World TB Day 2016. Resources include posters, postcards, a toolkit, a t-shirt design, and cap and sarong designs. The resources come in six languages - Arabic, Chinese, English, French, Spanish, and Russian.

This document shares best practices in engagement of health care providers in programmatic management of drug-resistant tuberculosis that have been documented in different countries and regions and implemented by different stakeholders. Case studies presented in the document are lessons learned for scale-up of public-private mix for the management of drug-resistant TB at country level.

This infographic provides a variety of information regarding latent TB infection in the United States, including the estimated number of people with latent TB infection, the cost-effectiveness of latent TB infection treatment, and who should be tested. Supporting graphics are available to use in print and online content.

This document is a compilation of survivor stories that feature the personal journeys of 15 individuals who have fought against TB disease.

This fact sheet provides information on the connection between TB and diabetes and outlines activities where TB and diabetes programs can collaborate.

This document highlights how the Ministries of Health of the 30 highest TB burden countries, and their partners, are beginning to adopt, adapt and implement the End TB Strategy.

This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.

This fact sheet provides information on latent tuberculosis infection (LTBI) for patients.

These guidelines aim to reduce morbidity and mortality related to TB and HIV-associated TB among people who inject drugs (PWID) through the integrated delivery of a comprehensive and holistic package of care. The guidelines provide an update of the 2008 Policy guidelines for collaborative TB and HIV services for injecting and other drug users: an integrated approach.